Evening Symposium
Chairs: R. Buhl (Mainz, Germany)
Aims: Organized by Novartis Pharma AG

Welcome and introduction R. Buhl (Mainz, Germany)
In the era of personalized medicine, what are the current unmet needs in asthma? J. FitzGerald (Vancouver (BC), Canada)
Inhaled therapies: can they breathe new life into asthma? A. Woodcock (Manchester (Greater Manchester), United Kingdom)
The pathway to inflammation in asthma: the role of the DP2 receptor O. Palomares (Madrid, Spain)
Anti-IgE therapy: current knowledge and future perspective R. Buhl (Mainz, Germany)
Chair-led expert discussion and audience Q&A R. Buhl (Mainz, Germany) J. FitzGerald (Vancouver (BC), Canada) A. Woodcock (Manchester (Greater Manchester), United Kingdom) O. Palomares (Madrid, Spain)